Effects of Chemically Modified Messenger RNA on Protein Expression

Bioconjugate Chemistry

Volumn 27, Issue 3, 2016, Pages 849-853

  Li, Bin ^a   Luo, Xiao ^a   Dong, Yizhou ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b The Ohio State University   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; CELL CULTURE; CHEMICAL MODIFICATION; NUCLEOTIDES; RNA;

CHEMICALLY MODIFIED; CONDITION; CORRELATION ANALYSIS; ENHANCED GREEN FLUORESCENT PROTEIN; EXPRESSION ANALYSIS; EXPRESSION LEVELS; FIREFLY LUCIFERASE; MESSENGER RNA; MODIFIED NUCLEOTIDES; PROTEIN EXPRESSIONS;

PROTEINS;

5 METHOXYURIDINE; COMPLEMENTARY DNA; ENHANCED GREEN FLUORESCENT PROTEIN; LUCIFERASE; MESSENGER RNA; N 1 METHYLPSEUDOURIDINE; NUCLEOTIDE; PSEUDOURIDINE; UNCLASSIFIED DRUG; PROTEIN;

ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; IN VITRO STUDY; LIVER CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; RNA TRANSLATION; CELL LINE; GENETICS; HUMAN; PROTEIN PROCESSING;

CELL LINE; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; RNA, MESSENGER;

EID: 84962287338     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.6b00090     Document Type: Article

References (21)

1. Sahin, U., Kariko, K., and Tureci, O. (2014) mRNA-based therapeutics - developing a new class of drugs Nat. Rev. Drug Discovery 13, 759-780 10.1038/nrd4278
2. Islam, M. A., Reesor, E. K., Xu, Y., Zope, H. R., Zetter, B. R., and Shi, J. (2015) Biomaterials for mRNA delivery Biomater. Sci. 3, 1519-1533 10.1039/C5BM00198F
3. McIvor, R. S. (2011) Therapeutic delivery of mRNA: The medium is the message Mol. Ther. 19, 822-823 10.1038/mt.2011.67
4. Pascolo, S. (2008) Vaccination with messenger RNA (mRNA) Handb. Exp. Pharmacol. 183, 221-235 10.1007/978-3-540-72167-11
5. Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., and Rejman, J. (2011) mRNA as gene therapeutic: How to control protein expression J. Controlled Release 150, 238-247 10.1016/j.jconrel.2010.10.020
6. Anguille, S., Smits, E. L., Lion, E., van Tendeloo, V. F., and Berneman, Z. N. (2014) Clinical use of dendritic cells for cancer therapy Lancet Oncol. 15, e257-267 10.1016/S1470-2045(13)70585-0
7. Zhao, Y., Moon, E., Carpenito, C., Paulos, C. M., Liu, X., Brennan, A. L., Chew, A., Carroll, R. G., Scholler, J., and Levine, B. L. et al. 2010, Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor Cancer Res. 70, 9053-9061 10.1158/0008-5472.CAN-10-2880
8. Li, B., Luo, X., Deng, B., Wang, J., McComb, D. W., Shi, Y., Gaensler, K. M., Tan, X., Dunn, A. L., and Kerlin, B. A. et al. 2015, An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo Nano Lett. 15, 8099-8107 10.1021/acs.nanolett.5b03528
9. Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., Fenton, O. S., and Anderson, D. G. (2015) Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs Nano Lett. 15, 7300-7306 10.1021/acs.nanolett.5b02497
10. Zangi, L., Lui, K. O., von Gise, A., Ma, Q., Ebina, W., Ptaszek, L. M., Spater, D., Xu, H., Tabebordbar, M., and Gorbatov, R. et al. 2013, Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction Nat. Biotechnol. 31, 898-907 10.1038/nbt.2682
11. Kormann, M. S., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., and Schams, A. et al. 2011, Expression of therapeutic proteins after delivery of chemically modified mRNA in mice Nat. Biotechnol. 29, 154-157 10.1038/nbt.1733
12. Thess, A., Grund, S., Mui, B. L., Hope, M. J., Baumhof, P., Fotin-Mleczek, M., and Schlake, T. (2015) Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals Mol. Ther. 23, 1456-1464 10.1038/mt.2015.103
13. Hendel, A., Bak, R. O., Clark, J. T., Kennedy, A. B., Ryan, D. E., Roy, S., Steinfeld, I., Lunstad, B. D., Kaiser, R. J., and Wilkens, A. B. et al. 2015, Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells Nat. Biotechnol. 33, 985-989 10.1038/nbt.3290
14. Wang, J., Exline, C. M., DeClercq, J. J., Llewellyn, G. N., Hayward, S. B., Li, P. W., Shivak, D. A., Surosky, R. T., Gregory, P. D., and Holmes, M. C. et al. 2015, Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors Nat. Biotechnol. 33, 1256-1263 10.1038/nbt.3408
15. Weissman, D. and Kariko, K. (2015) mRNA: Fulfilling the promise of gene therapy Mol. Ther. 23, 1416-1417 10.1038/mt.2015.138
16. Kariko, K., Ni, H. P., Capodici, J., Lamphier, M., and Weissman, D. (2004) mRNA is an endogenous ligand for Toll-like receptor 3 J. Biol. Chem. 279, 12542-12550 10.1074/jbc.M310175200
17. Kariko, K., Muramatsu, H., Keller, J. M., and Weissman, D. (2012) Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin Mol. Ther. 20, 948-953 10.1038/mt.2012.7
18. Kariko, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., and Weissman, D. (2008) Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability Mol. Ther. 16, 1833-1840 10.1038/mt.2008.200
19. Uchida, S., Kataoka, K., and Itaka, K. (2015) Screening of mRNA chemical modification to maximize protein expression with reduced immunogenicity Pharmaceutics 7, 137-151 10.3390/pharmaceutics7030137
20. Andries, O., Mc Cafferty, S., De Smedt, S. C., Weiss, R., Sanders, N. N., and Kitada, T. (2015) N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice J. Controlled Release 217, 337-344 10.1016/j.jconrel.2015.08.051
21. Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., and Kariko, K. (2010) Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation Nucleic Acids Res. 38, 5884-5892 10.1093/nar/gkq347